Correlation Between Medy Tox and Soulbrain Holdings

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Medy Tox and Soulbrain Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medy Tox and Soulbrain Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medy Tox and Soulbrain Holdings Co, you can compare the effects of market volatilities on Medy Tox and Soulbrain Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medy Tox with a short position of Soulbrain Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medy Tox and Soulbrain Holdings.

Diversification Opportunities for Medy Tox and Soulbrain Holdings

0.9
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Medy and Soulbrain is 0.9. Overlapping area represents the amount of risk that can be diversified away by holding Medy Tox and Soulbrain Holdings Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Soulbrain Holdings and Medy Tox is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medy Tox are associated (or correlated) with Soulbrain Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Soulbrain Holdings has no effect on the direction of Medy Tox i.e., Medy Tox and Soulbrain Holdings go up and down completely randomly.

Pair Corralation between Medy Tox and Soulbrain Holdings

Assuming the 90 days trading horizon Medy Tox is expected to under-perform the Soulbrain Holdings. But the stock apears to be less risky and, when comparing its historical volatility, Medy Tox is 1.68 times less risky than Soulbrain Holdings. The stock trades about -0.05 of its potential returns per unit of risk. The Soulbrain Holdings Co is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  4,390,000  in Soulbrain Holdings Co on September 4, 2024 and sell it today you would lose (885,000) from holding Soulbrain Holdings Co or give up 20.16% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

Medy Tox  vs.  Soulbrain Holdings Co

 Performance 
       Timeline  
Medy Tox 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medy Tox has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Soulbrain Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Soulbrain Holdings Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Medy Tox and Soulbrain Holdings Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Medy Tox and Soulbrain Holdings

The main advantage of trading using opposite Medy Tox and Soulbrain Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medy Tox position performs unexpectedly, Soulbrain Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Soulbrain Holdings will offset losses from the drop in Soulbrain Holdings' long position.
The idea behind Medy Tox and Soulbrain Holdings Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data